WO2001016158A3 - Molecules d'acide nucleique et proteines d'integrateur 2 de pontage et utilisations associees - Google Patents

Molecules d'acide nucleique et proteines d'integrateur 2 de pontage et utilisations associees Download PDF

Info

Publication number
WO2001016158A3
WO2001016158A3 PCT/US2000/023723 US0023723W WO0116158A3 WO 2001016158 A3 WO2001016158 A3 WO 2001016158A3 US 0023723 W US0023723 W US 0023723W WO 0116158 A3 WO0116158 A3 WO 0116158A3
Authority
WO
WIPO (PCT)
Prior art keywords
bin2
proteins
nucleic acid
acid molecules
uses therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/023723
Other languages
English (en)
Other versions
WO2001016158A2 (fr
Inventor
George C Prendergast
Kai Ge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Institute of Anatomy and Biology filed Critical Wistar Institute of Anatomy and Biology
Priority to AU73367/00A priority Critical patent/AU7336700A/en
Priority to US10/069,540 priority patent/US6831063B1/en
Publication of WO2001016158A2 publication Critical patent/WO2001016158A2/fr
Publication of WO2001016158A3 publication Critical patent/WO2001016158A3/fr
Anticipated expiration legal-status Critical
Priority to US10/976,492 priority patent/US7150968B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne des séquences Bin2 et des protéines codées par ces dernières; des compositions et des procédés dans lesquels on utilise ces séquences et ces protéines dans le diagnostic et le traitement des troubles sanguins, y compris l'hépatocarcinome; des oligonucléotides dérivés de séquences codant bin2, ainsi que des compositions et des procédés dans lesquels on les utilise à des fins de diagnostic et de traitement thérapeutique.
PCT/US2000/023723 1999-08-31 2000-08-30 Molecules d'acide nucleique et proteines d'integrateur 2 de pontage et utilisations associees Ceased WO2001016158A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU73367/00A AU7336700A (en) 1999-08-31 2000-08-30 Bridging integrator-2 (bin2) nucleic acid molecules and proteins and uses therefor
US10/069,540 US6831063B1 (en) 1999-08-31 2000-08-30 Bridging Integrator-2(Bin2) nucleic acid molecules and proteins and uses therefor
US10/976,492 US7150968B2 (en) 1999-08-31 2004-10-29 Bridging INtegrator-2 (Bin2) nucleic acid molecules and proteins and uses therefor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15155499P 1999-08-31 1999-08-31
US60/151,554 1999-08-31

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10069540 A-371-Of-International 2000-08-30
US10/976,492 Division US7150968B2 (en) 1999-08-31 2004-10-29 Bridging INtegrator-2 (Bin2) nucleic acid molecules and proteins and uses therefor

Publications (2)

Publication Number Publication Date
WO2001016158A2 WO2001016158A2 (fr) 2001-03-08
WO2001016158A3 true WO2001016158A3 (fr) 2001-06-07

Family

ID=22539287

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/023723 Ceased WO2001016158A2 (fr) 1999-08-31 2000-08-30 Molecules d'acide nucleique et proteines d'integrateur 2 de pontage et utilisations associees

Country Status (2)

Country Link
AU (1) AU7336700A (fr)
WO (1) WO2001016158A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070037186A1 (en) 2005-05-20 2007-02-15 Yuqiu Jiang Thyroid fine needle aspiration molecular assay
CN112592403B (zh) * 2020-12-31 2022-04-15 中南大学湘雅二医院 cBIN1抗体及其应用
CN113957086B (zh) * 2021-12-11 2022-10-11 浙江大学 SlBIN2基因在调控番茄果实成熟和类胡萝卜素合成中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605830A (en) * 1995-05-05 1997-02-25 The Wistar Institute Of Anatomy & Biology Murine and human c-Myc interacting protein
US5958753A (en) * 1996-08-29 1999-09-28 The Wistar Institute Of Anatomy And Biology Nucleic acid sequences encoding Bau, a Bin1 interacting protein, and vectors and host cells containing same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605830A (en) * 1995-05-05 1997-02-25 The Wistar Institute Of Anatomy & Biology Murine and human c-Myc interacting protein
US5958753A (en) * 1996-08-29 1999-09-28 The Wistar Institute Of Anatomy And Biology Nucleic acid sequences encoding Bau, a Bin1 interacting protein, and vectors and host cells containing same

Also Published As

Publication number Publication date
WO2001016158A2 (fr) 2001-03-08
AU7336700A (en) 2001-03-26

Similar Documents

Publication Publication Date Title
MXPA03002413A (es) Moleculas tipo b7 y uso de las mismas.
WO2002002624A3 (fr) Molecules de type b7 et utilisation de ces molecules
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
WO2001070977A3 (fr) Molecules analogues au recepteur du facteur de croissance du fibroblaste, et leurs utilisations
CA2257133A1 (fr) Variantes hyperactives de la desoxyribonuclease i humaine
WO2001092308A3 (fr) Polypeptides a noeud de cystines: molecules 'cloaked-2' et leurs utilisations
WO1999054461A3 (fr) Sequences d'acide nucleique humaines provenant d'une tumeur de l'endometre
WO1999047669A3 (fr) Sequences d'acide nucleique humain tirees de tissus de tumeurs du sein
WO2002029086A3 (fr) Sequences d'acide nucleique differentiellement exprimees dans un tissu cancereux
AU8881201A (en) Tnf receptor-like molecules and uses thereof
WO1998014596A3 (fr) Tyrosine phosphatases proteiques associees a des maladies
WO2001061007A3 (fr) Molecules du facteur 23 de croissance de fibroblastes et procedes d'utilisation correspondants
WO2001068854A3 (fr) Molecules s'apparentant au facteur de croissance des fibroblastes et leurs utilisations
WO2002010388A3 (fr) Molecules du type recepteur de complement c3b/c4b et utilisations de ces molecules
WO2001042474A3 (fr) Molecules de type interferon et utilisations
WO2003102185A3 (fr) Procedes et compositions pour traiter une neoplasie associee aux molecules d'acides nucleiques de a1 et a2 de hnrnp
WO2004048522A3 (fr) Modulation de l'expression de la proteine 2 interagissant avec l'huntingtine
WO2004076614A3 (fr) Sequences d'acide nucleique humaines issues de carcinomes de la prostate
WO1999002704A3 (fr) Phosphatase a double specificite et procedes d'utilisation
WO1999054447A3 (fr) Sequences d'acide nucleique provenant de tissus tumoraux de la vessie
WO2004043394A3 (fr) Modulation de l'expression de la proteine 1 interagissant avec la huntingtine
WO2004085614A3 (fr) Molecules d'acides nucleiques a regulation differentielle dans un trouble bipolaire et leurs utilisations
WO2001016158A3 (fr) Molecules d'acide nucleique et proteines d'integrateur 2 de pontage et utilisations associees
MXPA03010728A (es) Moleculas de proteina-2 relacionadas con b7 y uso de las mismas.
WO1997040134A3 (fr) Dnase ii humaine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10069540

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP